Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Key Player in Diabetic Kidney Disease Revealed
Saturday, July 25, 2015
Discovery could lead to new and better diagnostic marker for chronic kidney disease.

Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?
Monday, July 20, 2015
An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic.

Study Reveals Improved Way to Interpret High-Throughput Biological Data
Friday, July 17, 2015
A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.

Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Tuesday, July 14, 2015
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.

Researchers Link Liver Disease and Drug Metabolism
Monday, July 13, 2015
Researchers have discovered that nonalcoholic steatohepatitis, an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.

Darin Leigh Joins Metabolon as Chief Commercial Officer
Tuesday, July 07, 2015
New role to lead commercial strategy for biomarker discovery, precision medicine, and diagnostics products and services.

Scientists Create Synthetic Membranes That Grow Like Living Cells
Wednesday, July 01, 2015
Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.

Potential New Class of Cancer Drugs
Tuesday, June 30, 2015
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.

EU Recommends Approval for Alexion's Rare Disease Drugs
Tuesday, June 30, 2015
Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 1545
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!